| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |